BANK OF MONTREAL /CAN/ - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$62,000
+51.2%
5,841
+48.6%
0.00%
Q3 2019$41,000
-21.2%
3,932
+16.6%
0.00%
Q2 2019$52,000
+1200.0%
3,371
+730.3%
0.00%
Q4 2018$4,000
+33.3%
406
+107.1%
0.00%
Q3 2018$3,0000.0%1960.0%0.00%
Q2 2018$3,000
-96.7%
196
-97.1%
0.00%
Q4 2016$90,000
+50.0%
6,836
+24.8%
0.00%
Q3 2016$60,000
+1400.0%
5,478
+2182.5%
0.00%
Q2 2014$4,0002400.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Eventide Asset Management 579,800$7,224,0001.01%
VHCP Management, LLC 71,000$884,0000.40%
Healthcare Value Capital, LLC 16,464$205,0000.20%
CARL DOMINO INC 22,196$277,0000.15%
TFS CAPITAL LLC 120,112$1,497,0000.13%
Private Capital Advisors, Inc. 31,064$387,0000.12%
Artal Group S.A. 170,000$2,118,0000.08%
TimesSquare Capital Management, LLC 801,225$9,983,0000.06%
Baker Brothers Advisors 338,671$4,220,0000.05%
STONERIDGE INVESTMENT PARTNERS LLC 19,399$242,0000.04%
View complete list of STEMLINE THERAPEUTICS INC shareholders